Ind-Swift Laboratories Ltd, commonly referred to as Ind-Swift, is a prominent player in the pharmaceutical industry, headquartered in India. Established in 1986, the company has made significant strides in the development and manufacturing of a diverse range of pharmaceutical products, including active pharmaceutical ingredients (APIs) and finished dosage forms. With a strong operational presence across various regions, Ind-Swift is recognised for its commitment to quality and innovation. The company’s core offerings include a wide array of generic medications, which are distinguished by their adherence to stringent quality standards and regulatory compliance. Ind-Swift has achieved notable milestones, including certifications from major global regulatory bodies, solidifying its position as a trusted supplier in the competitive pharmaceutical landscape. Through its dedication to research and development, Ind-Swift continues to enhance its market presence and contribute to the healthcare sector.
How does Ind-Swift's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Ind-Swift's score of 16 is lower than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Ind-Swift, headquartered in India, currently does not have specific carbon emissions data available for recent years, as indicated by the absence of reported figures. Consequently, there are no recorded emissions in kg CO2e, nor are there any documented reduction targets or climate pledges. The company has not inherited any emissions data from a parent or related organization, and there are no specific initiatives or commitments outlined in relation to the Science Based Targets initiative (SBTi) or other climate frameworks. As such, Ind-Swift's climate commitments and emissions performance remain undefined, highlighting a potential area for future development in sustainability practices and reporting.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Ind-Swift has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
